AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 182 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $423,329 | +4.8% | 66,666 | 0.0% | 0.32% | -2.1% |
| Q1 2024 | $403,996 | -0.2% | 66,666 | 0.0% | 0.33% | -7.1% |
| Q4 2023 | $404,663 | +43.8% | 66,666 | 0.0% | 0.35% | +28.7% |
| Q3 2023 | $281,331 | +3.5% | 66,666 | -24.0% | 0.28% | +9.1% |
| Q2 2023 | $271,765 | +123.0% | 87,666 | 0.0% | 0.25% | +123.0% |
| Q1 2023 | $121,856 | -30.2% | 87,666 | 0.0% | 0.11% | -34.3% |
| Q4 2022 | $174,455 | -1.4% | 87,666 | 0.0% | 0.17% | -11.8% |
| Q3 2022 | $177,000 | -36.6% | 87,666 | 0.0% | 0.20% | -31.8% |
| Q2 2022 | $279,000 | -23.8% | 87,666 | 0.0% | 0.29% | -8.3% |
| Q1 2022 | $366,000 | -12.9% | 87,666 | 0.0% | 0.31% | -12.4% |
| Q4 2021 | $420,000 | -10.3% | 87,666 | 0.0% | 0.36% | -16.0% |
| Q3 2021 | $468,000 | +4.2% | 87,666 | 0.0% | 0.42% | +3.9% |
| Q2 2021 | $449,000 | -23.9% | 87,666 | 0.0% | 0.41% | -27.9% |
| Q1 2021 | $590,000 | +47.1% | 87,666 | 0.0% | 0.57% | +41.1% |
| Q4 2020 | $401,000 | – | 87,666 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $42,827,417 | 3.52% |
| TPG GP A, LLC | 12,328,767 | $24,534,246 | 0.48% |
| CM Management, LLC | 150,000 | $299 | 0.36% |
| Signature Wealth Management Partners, LLC | 87,666 | $174,455 | 0.17% |
| Eversept Partners, LP | 830,960 | $1,653,610 | 0.14% |
| Tranquilli Financial Advisor LLC | 71,414 | $142,114 | 0.11% |
| Hedges Asset Management LLC | 50,000 | $99,500 | 0.09% |
| XTX Topco Ltd | 191,502 | $381,089 | 0.08% |
| EMC Capital Management | 40,613 | $81 | 0.07% |
| Orbimed Advisors | 1,583,490 | $3,151,145 | 0.06% |